Saturday - September 26, 2026
AAM and Biosimilars Council Comment on GDUFA and BsUFA User Fee Negotiations and Reauthorization
September 26, 2026
WASHINGTON, Sept. 26 (TNSrpt) -- The Association for Accessible Medicines issued the following statement:

* * *

AAM and Biosimilars Council Comment on GDUFA and BsUFA User Fee Negotiations and Reauthorization

WASHINGTON (September 25, 2026) -- The Association for Accessible Medicines and the Biosimilars Council today released the following statement from President and CEO John Murphy III on recent GDUFA and upcoming BsUFA public meetings, negotiations, and . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products